Immunotropic Effects in Cultured Human Blood Mononuclear Cells Pre‐exposed to Low‐Level 1300 MHz Pulse‐Modulated Microwave Field
暂无分享,去创建一个
Wanda Stankiewicz | S. Szmigielski | R. Kubacki | R. Kubacki | W. Stankiewicz | M. Dąbrowski | E. Sobiczewska | S. Szmigielski | M. P. Dabrowski | Elzbieta Sobiczewska
[1] A. Guy,et al. SAR in rats exposed in 2,450-MHz circularly polarized waveguides. , 1984, Bioelectromagnetics.
[2] S. Szmigielski,et al. [Immunotropic effects of electromagnetic fields in the range of radio- and microwave frequencies]. , 2001, Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego.
[3] W. R. Adey,et al. Suppression of T-lymphocyte cytotoxicity following exposure to sinusoidally amplitude-modulated fields. , 1983, Bioelectromagnetics.
[4] Arthur W. Guy,et al. Circularly polarized 2450-MHz waveguide system for chronic exposure of small animals to microwaves , 1979 .
[5] Eduardo G. Moros,et al. Cytogenetic Studies in Human Blood Lymphocytes Exposed In Vitro to Radiofrequency Radiation at a Cellular Telephone Frequency (835.62 MHz, FDMA) , 2001, Radiation research.
[6] K. Matsushima,et al. There is more than one interleukin 1. , 1986, Immunology today.
[7] M. Dana,et al. Topical interleukin 1 receptor antagonist promotes corneal transplant survival. , 1997, Transplantation.
[8] C. Janeway,et al. Induction of receptors for interleukin 2 requires T cell Ag:Ia receptor crosslinking and interleukin 1. , 1984, Lymphokine research.
[9] E. Novoselova,et al. Microwaves and cellular immunity. I. Effect of whole body microwave irradiation on tumor necrosis factor production in mouse cells. , 1999, Bioelectrochemistry and bioenergetics.
[10] M. Geffard,et al. Antibody responses of mice exposed to low-power microwaves under combined, pulse-and-amplitude modulation. , 1991, Bioelectromagnetics.
[11] S. Szmigielski,et al. Competition of IL-1 and IL-1ra determines lymphocyte response to delayed stimulation with PHA. , 2001, Mediators of inflammation.
[12] C. Dinarello,et al. Interleukin-1 receptor antagonist competitively inhibits the binding of interleukin-1 to the type II interleukin-1 receptor. , 1991, The Journal of biological chemistry.
[13] C. Dinarello. The role of the interleukin-1-receptor antagonist in blocking inflammation mediated by interleukin-1. , 2000, The New England journal of medicine.
[14] M. Dąbrowski,et al. Immunologic and Clinical Evaluation of Multiple Sclerosis Patients Treated with Corticosteroids and/or Calf Thymic Hormones , 1987, Annals of the New York Academy of Sciences.
[15] S. T. Lu,et al. Mitogen responsiveness after exposure of influenza virus-infected human mononuclear leukocytes to continuous or pulse-modulated radiofrequency radiation. , 1987, Radiation research.
[16] D. Dripps,et al. Interleukin-1 (IL-1) receptor antagonist binds to the 80-kDa IL-1 receptor but does not initiate IL-1 signal transduction. , 1991, The Journal of biological chemistry.
[17] B. Shao,et al. The Effects of Microwaves on the Immune System in Mice , 1989 .
[18] M. Sharma,et al. Effect of chronic microwave radiation on T cell-mediated immunity in the rabbit , 1991, International journal of biometeorology.
[19] E. Shevach. Regulatory T cells in autoimmmunity*. , 2000, Annual review of immunology.
[20] G. Camussi,et al. Interleukin-1 receptors and receptor antagonist in haemodialysis. , 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[21] W. STODOLNIK-BARAŃSKA. Lymphoblastoid Transformation of Lymphocytes in vitro after Microwave Irradiation , 1967, Nature.
[22] E. Novoselova,et al. Microwaves and cellular immunity. II. Immunostimulating effects of microwaves and naturally occurring antioxidant nutrients. , 1999, Bioelectrochemistry and bioenergetics.
[23] M. Mizuno,et al. Increased production of interleukin-1beta and interleukin-1 receptor antagonist by peripheral blood mononuclear cells in undialyzed chronic renal failure. , 1997, Nephron.
[24] M. T. Brewer,et al. Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist , 1990, Nature.